Voleon Capital Management’s Boston Scientific BSX Stock Holding History

Voleon Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$346K	Sell	8,105 -15,272	-65%	-$829K	0.01%	652
2026 Q1	$1.47M	Sell	23,377 -254,141	-92%	-$20.3M	0.03%	383
2025 Q4	$26.5M	Buy	277,518 +65,228	+31%	+$6.39M	0.57%	31
2025 Q3	$20.7M	Buy	212,290 +124,835	+143%	+$12.9M	0.51%	31
2025 Q2	$9.39M	Buy	87,455 +51,095	+141%	+$5.17M	0.52%	36
2025 Q1	$3.67M	Sell	36,360 -19,632	-35%	-$1.98M	0.29%	85
2024 Q4	$5M	Buy	+55,992	New	+$4.93M	0.37%	76
2020 Q1	–	Sell	-174,000	Closed	-$7.87M	–	29
2019 Q4	$7.87M	Hold	174,000	–	–	0.46%	45
2019 Q3	$7.08M	Sell	174,000 -47,000	-21%	-$1.99M	0.55%	44
2019 Q2	$9.5M	Buy	+221,000	New	+$8.5M	0.54%	49

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Voleon Capital Management's BSX Position: Q2 2026 in Review

Voleon Capital Management reduced its Boston Scientific (BSX) stake by 65% in Q2 2026, selling an estimated $829K and leaving 8,105 shares worth $346K. The position accounts for 0.01% of the portfolio, ranked #652.

Voleon Capital Management first reported a position in BSX in Q2 2019 and has held it in 10 quarters since. The position peaked at $26.5M in Q4 2025. 1,474 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Voleon Capital Management held 8,105 shares of Boston Scientific worth $346K as of Q2 2026.
Voleon Capital Management sold 15,272 Boston Scientific shares in Q2 2026, an estimated $829K.
Boston Scientific made up 0.01% of Voleon Capital Management's portfolio in Q2 2026, its #652 holding.
Voleon Capital Management first reported a position in Boston Scientific in Q2 2019 and has held it in 10 quarters since.
Voleon Capital Management's Boston Scientific position peaked at $26.5M in Q4 2025.
1,474 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Voleon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.